Martin Rachmeler

805 total citations
19 papers, 663 citations indexed

About

Martin Rachmeler is a scholar working on Molecular Biology, Pharmacology and Pharmaceutical Science. According to data from OpenAlex, Martin Rachmeler has authored 19 papers receiving a total of 663 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 2 papers in Pharmacology and 2 papers in Pharmaceutical Science. Recurrent topics in Martin Rachmeler's work include RNA Interference and Gene Delivery (5 papers), Biochemical and Molecular Research (3 papers) and Chemical Synthesis and Analysis (2 papers). Martin Rachmeler is often cited by papers focused on RNA Interference and Gene Delivery (5 papers), Biochemical and Molecular Research (3 papers) and Chemical Synthesis and Analysis (2 papers). Martin Rachmeler collaborates with scholars based in United States. Martin Rachmeler's co-authors include Charles Yanofsky, Jonathan L. Rosner, John C. Gerhart, Saul Kit, D. R. Dubbs, Henry L. Nadler, Arthur B. Pardee, Peter N. Gray, Terry C. Johnson and Robert J. Kinders and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Journal of Cell Biology.

In The Last Decade

Martin Rachmeler

19 papers receiving 562 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martin Rachmeler United States 12 485 77 76 70 64 19 663
Carl L. Zimmerman United States 5 532 1.1× 52 0.7× 48 0.6× 40 0.6× 54 0.8× 6 792
R.J. Hilmoe United States 17 944 1.9× 90 1.2× 70 0.9× 59 0.8× 78 1.2× 20 1.2k
Jeanette R. Piperno United States 10 498 1.0× 144 1.9× 51 0.7× 157 2.2× 124 1.9× 11 836
Athanasios E. Evangelopoulos Greece 11 414 0.9× 59 0.8× 31 0.4× 45 0.6× 100 1.6× 39 613
Jean Barrollier Germany 9 403 0.8× 35 0.5× 37 0.5× 82 1.2× 58 0.9× 14 743
J. Logan Irvin United States 20 695 1.4× 136 1.8× 134 1.8× 29 0.4× 55 0.9× 53 1.1k
R. V. Tomlinson Canada 10 553 1.1× 61 0.8× 53 0.7× 27 0.4× 24 0.4× 21 837
Munehiko Yukioka Japan 16 547 1.1× 113 1.5× 49 0.6× 21 0.3× 39 0.6× 51 688
Emil Schiltz Germany 15 462 1.0× 122 1.6× 46 0.6× 46 0.7× 57 0.9× 25 666
Takuzo Oda Japan 19 635 1.3× 88 1.1× 109 1.4× 25 0.4× 28 0.4× 102 967

Countries citing papers authored by Martin Rachmeler

Since Specialization
Citations

This map shows the geographic impact of Martin Rachmeler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Rachmeler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Rachmeler more than expected).

Fields of papers citing papers by Martin Rachmeler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Rachmeler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Rachmeler. The network helps show where Martin Rachmeler may publish in the future.

Co-authorship network of co-authors of Martin Rachmeler

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Rachmeler. A scholar is included among the top collaborators of Martin Rachmeler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Rachmeler. Martin Rachmeler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Kinders, Robert J., Terry C. Johnson, & Martin Rachmeler. (1979). An inhibitor of protein synthesis prepared by protease treatment of mouse cerebral cortex cells. Life Sciences. 24(1). 43–50. 14 indexed citations
2.
Rachmeler, Martin, et al.. (1978). Growth and metabolism of fucosylated plasma-membrane glycoproteins in mouse neuroblastoma N2a cells. Biochemical Journal. 176(3). 695–704. 4 indexed citations
3.
Christensen, Mary & Martin Rachmeler. (1976). Studies on the in Vitro formation of infectious DNA-protein aggregates from SV40 components. Virology. 75(2). 433–441. 3 indexed citations
4.
Somers, Kenneth D., Martin Rachmeler, & Mary Christensen. (1975). Cyclic AMP-mediated transformation of rat cells transformed by temperature-sensitive mouse sarcoma virus. Nature. 257(5521). 58–60. 11 indexed citations
5.
Dubbs, D. R., Martin Rachmeler, & Saul Kit. (1974). Recombination between temperature-sensitive mutants of simian virus 40. Virology. 57(1). 161–174. 72 indexed citations
6.
Rachmeler, Martin, et al.. (1974). INHIBITION OF CELL GROWTH IN THE G1 PHASE BY ADENOSINE 3',5'-CYCLIC MONOPHOSPHATE. The Journal of Cell Biology. 60(1). 249–257. 51 indexed citations
7.
Rachmeler, Martin, et al.. (1972). EFFECT OF ADENOSINE 3'-5'-CYCLIC MONOPHOSPHATE ON CELL PROLIFERATION. The Journal of Cell Biology. 55(1). 19–31. 124 indexed citations
8.
Nadler, Henry L., et al.. (1970). Interallelic Complementation in Hybrid Cells Derived from Human Diploid Strains Deficient in Galactose-1-Phosphate Uridyl Transferase Activity. Proceedings of the National Academy of Sciences. 67(2). 976–982. 60 indexed citations
9.
Lazda, Velta A., Jason L. Starr, & Martin Rachmeler. (1968). The Synthesis of Ribonucleic Acid during Early Antibody Induction. The Journal of Immunology. 101(2). 349–358. 5 indexed citations
10.
Lazda, Velta A., Jason L. Starr, & Martin Rachmeler. (1968). The Metabolism of Messenger RNA Synthesized after Primary Immunization. The Journal of Immunology. 101(2). 359–365. 7 indexed citations
11.
Gray, Peter N. & Martin Rachmeler. (1967). The effects of 5-fluorouracil and 6-thioguanine incorporation on the amino acid acceptor activity of Escherichia coli tRNA. Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis. 138(2). 432–435. 16 indexed citations
12.
Rachmeler, Martin. (1967). Altered Protein Formation as a Result of Suppression in Neurospora Crassa. Journal of Bacteriology. 93(6). 1863–1868. 2 indexed citations
13.
Rachmeler, Martin, et al.. (1966). Mechanisms of Antibiotic Resistance Determined by Resistance-Transfer Factors. Journal of Bacteriology. 92(2). 358–365. 25 indexed citations
14.
Lawrence, Patricia, et al.. (1964). MUTATIONAL ALTERATION OF PERMEABILITY IN NEUROSPORA: EFFECTS ON GROWTH AND THE UPTAKE OF CERTAIN AMINO ACIDS AND RELATED COMPOUNDS. Genetics. 50(6). 1383–1402. 17 indexed citations
15.
Rachmeler, Martin & Arthur B. Pardee. (1963). Loss of viability and β-galactosidase-froming ability as a consequence of tritium decay in Escherichia coli. Biochimica et Biophysica Acta (BBA) - Specialized Section on Nucleic Acids and Related Subjects. 68. 62–67. 16 indexed citations
16.
Rachmeler, Martin & Arthur B. Pardee. (1963). Loss of viability and β-galactosidase-froming ability as a consequence of tritium decay in Escherichia coli. Biochimica et Biophysica Acta. 68. 62–67. 3 indexed citations
17.
Rachmeler, Martin & Charles Yanofsky. (1961). BIOCHEMICAL, IMMUNOLOGICAL, AND GENETIC STUDIES WITH A NEW TYPE OF TRYPTOPHAN SYNTHETASE MUTANT OF NEUROSPORA CRASSA. Journal of Bacteriology. 81(6). 955–963. 17 indexed citations
18.
Rachmeler, Martin, John C. Gerhart, & Jonathan L. Rosner. (1961). Limited thymidine uptake in Escherichia coli due to an inducible thymidine phosphorylase. Biochimica et Biophysica Acta. 49(1). 222–225. 104 indexed citations
19.
Yanofsky, Charles & Martin Rachmeler. (1958). The exclusion of free indole as an intermediate in the biosynthesis of tryptophan in Neurospora crassa. Biochimica et Biophysica Acta. 28(3). 640–641. 112 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carl L. Zimmerman Breakdown of academic impact, for papers by R.J. Hilmoe Breakdown of academic impact, for papers by Jeanette R. Piperno Breakdown of academic impact, for papers by Athanasios E. Evangelopoulos Breakdown of academic impact, for papers by Jean Barrollier Breakdown of academic impact, for papers by J. Logan Irvin Breakdown of academic impact, for papers by R. V. Tomlinson Breakdown of academic impact, for papers by Munehiko Yukioka Breakdown of academic impact, for papers by Emil Schiltz Breakdown of academic impact, for papers by Takuzo Oda
Rankless by CCL
2026